Your browser doesn't support javascript.
loading
Early and Midterm Outcomes of Valve-Sparing Aortic Root Replacement-Reimplantation Technique.
Cevasco, Marisa; McGurk, Siobhan; Yammine, Maroun; Sharma, Lokesh; Ejiofor, Julius; Norman, Anthony; Singh, Michael N; Shekar, Prem.
Afiliación
  • Cevasco M; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • McGurk S; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Yammine M; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sharma L; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ejiofor J; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Norman A; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Singh MN; Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Shekar P; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Aorta (Stamford) ; 6(5): 113-117, 2018 Oct.
Article en En | MEDLINE | ID: mdl-30934106
ABSTRACT

BACKGROUND:

Valve-sparing aortic root replacement (VSARR) is an increasingly popular alternative to traditional aortic root replacement for aortic root aneurysm disease with a normal aortic valve. We evaluated the early and midterm outcomes of VSARR-reimplantation technique (VSARR-RT) done at a single institution over a decade. MATERIALS AND

METHODS:

We performed a retrospective study of all patients who underwent VSARR-RT between January 2004 and July 2014.

RESULTS:

A total of 85 patients underwent VSARR-RT. Median time to latest echocardiographic follow-up was 4 years (range 15-72 months). Total observation time was 491 patient years. Mean age was 44.6 ± 14.3 years, and 13 (15%) were women. Thirty-nine (46%) patients had a connective tissue disorder and 6 (7%) had a bicuspid aortic valve. Thirty-three (39%) patients underwent concomitant procedures, including coronary artery bypass grafting (n = 9, 11%), mitral valve repair (n = 8, 9%), and aortic hemi-arch replacement (n = 7, 8%). There were no operative deaths or in-house mortality and no postoperative strokes. Kaplan-Meier analysis demonstrated survival of 99% (95% confidence interval [CI] 97-100%) at 2 years and 98% (95% CI 97-100%) at 8 years. Freedom from reoperation was 95.8% (95% CI 91.2-100%) at 8 years. Freedom from endocarditis was 100% at 8 years. At the last echocardiographic follow-up, 95% of patients were free of severe aortic regurgitation (AR) and 82% free of moderate AR. Of the four patients who had severe AR, three underwent reoperations and received prosthetic valves and one is being clinically monitored.

CONCLUSION:

This study reports early and midterm outcomes after VSARR-RT at our institution, including those patients who underwent a VSARR-RT procedure combined with other procedures. Further follow-up remains necessary to determine long-term outcomes.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Aorta (Stamford) Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Aorta (Stamford) Año: 2018 Tipo del documento: Article
...